Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side

Not Applicable

Not yet recruiting

• Conditions: Diabetes Mellitus; Diabetic Retinopathy (DR)

• Registration Number: NCT06968611
• Lead Sponsor: Orbis

Brief Summary

The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses.

The main questions it aims to answer are:

1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments?

2. What is the cost-effectiveness, measured as total intervention cost per additional patient complying with the suggested exam?

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-05-05
• Study First Submitted QC: 2025-05-12
• Study First Posted: 2025-05-13
• Status Verified: 2025-07
• Study Start: 2025-07-01
• Last Update Submitted: 2025-07-09
• Last Update Posted: 2025-07-14
• Primary Completion: 2026-12
• Study Completion: 2026-12-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 640

Inclusion Criteria

• Diagnosed with DM within the last 6 months
• Over 30 years of age
• Currently treated at the Dinajpur Diabetes Hospital
• Possess a mobile phone to receive voice messages
• Willingness to participate in the study, and ability to give informed consent

Exclusion Criteria

• Other significant causes of vision loss
• Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Proportion of patients completing their diabetes or DR exam within 3 weeks of the scheduled date.	3 weeks following scheduled exam date

Secondary Outcome Measures

Name	Time	Method
Cost-effectiveness, measured as total intervention cost per additional patient adherence with the suggested exam.	Enrollment to 3 weeks following suggested exam date

Trial Locations

Locations (2)

Dinajpur Diabetes & Swasthoseba Hospital; 🇧🇩 Dinajpur Sadar, Bangladesh

Gausul Azam BNSB Eye Hospital; 🇧🇩 Dinajpur, Bangladesh